Amalia Mapurunga Almeida

Amalia Mapurunga Almeida

Auto-generated profile, based on publicly available information

Amalia Mapurunga Almeida

Instituto de Medicina Integral Prof. Fernando Figueira, Brasil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Revista Brasileira de Saúde Materno Infantil
Verified
Journal Article
Open access
PDF file
ELEduardo Jorge Fonseca Lima
Eduardo Jorge Fonseca Lima
AAAmalia Mapurunga Almeida
Amalia Mapurunga Almeida
RKRenato Kfouri
Renato Kfouri
Vaccine candidates against COVID-19 have diverse compositions, from traditional inac-tivated virus vaccines to various new-generation vaccines. Currently, approximately 175 research teams worldwide are studying various vaccine possibilities as the necessityto vacci-nate the entire population against the SARS-CoV-2 virus is urgent. Although, the development of a safe and effective COVID-19 vaccine is not easy, the manufacturing, distribution, and administration of the vaccine can also face extraordinary challenges. In this review, we enhance some of the current knowledge regarding the clinical trial phases on different COVID-19 vaccine candidates, its potential strengths and disadvantages, and to discuss ethical aspects and their chances of success in large-scale applications.